You are here

Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund

BT_20180312_ABFUND12_3345787.jpg
Sprim co-founder Michael Shleifer (left) and Tikehau Investment Management chairman Bruno de Pampelonne. The two firms have committed US$50m to venture capital fund TKS1.

Singapore

LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.

European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund...

sentifi.com

Market voices on: